{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:33:31Z","timestamp":1785857611800,"version":"3.56.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.ejca.2023.02.012","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T19:28:21Z","timestamp":1677266901000},"page":"40-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Spatial immunophenotyping of the tumour microenvironment in non\u2013small cell lung cancer"],"prefix":"10.1016","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8804-1012","authenticated-orcid":false,"given":"Max","family":"Backman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3783-7256","authenticated-orcid":false,"given":"Carina","family":"Strell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8206-5294","authenticated-orcid":false,"given":"Amanda","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5294-7808","authenticated-orcid":false,"given":"Johanna S.M.","family":"Mattsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedvig","family":"Elfving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Brunnstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aine","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7113-2834","authenticated-orcid":false,"given":"Martina","family":"Bosic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4988-6933","authenticated-orcid":false,"given":"Miklos","family":"Gulyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5787-0072","authenticated-orcid":false,"given":"Johan","family":"Isaksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2226-3517","authenticated-orcid":false,"given":"Johan","family":"Botling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klas","family":"K\u00e4rre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Jirstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Lamberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Pont\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Leandersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4394-2634","authenticated-orcid":false,"given":"Artur","family":"Mezheyeuski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1210-5961","authenticated-orcid":false,"given":"Patrick","family":"Micke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2023.02.012_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejca.2018.11.002","article-title":"Predictive biomarkers of response for immune checkpoint inhibitors in non-small-cell lung cancer","volume":"106","author":"Prelaj","year":"2019","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2023.02.012_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.immuni.2019.12.011","article-title":"Top 10 challenges in cancer immunotherapy","volume":"52","author":"Hegde","year":"2020","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.ejca.2023.02.012_bib3","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jtho.2021.03.016","article-title":"Efficacy and safety of first-line immunotherapy combinations for advanced NSCLC: a systematic review and network meta-analysis","volume":"16","author":"Liu","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"12","key":"10.1016\/j.ejca.2023.02.012_bib4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/s41573-021-00155-y","article-title":"Beyond immune checkpoint blockade: emerging immunological strategies","volume":"20","author":"Kubli","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"10.1016\/j.ejca.2023.02.012_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/path.5026","article-title":"Multispectral imaging for quantitative and compartment-specific immune infiltrates reveals distinct immune profiles that classify lung cancer patients","volume":"244","author":"Mezheyeuski","year":"2018","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/j.ejca.2023.02.012_bib6","doi-asserted-by":"crossref","first-page":"dju435","DOI":"10.1093\/jnci\/dju435","article-title":"Objective measurement and clinical significance of TILs in non-small cell lung cancer","volume":"107","author":"Schalper","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.ejca.2023.02.012_bib7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jtho.2016.01.015","article-title":"The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer","volume":"11","author":"Bremnes","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ejca.2023.02.012_bib8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejca.2020.04.040","article-title":"Chemoradiotherapy efficacy is predicted by intra-tumour CD8+\/FoxP3+ double positive T cell density in locally advanced N2 non-small-cell lung carcinoma","volume":"135","author":"Boulle","year":"2020","journal-title":"Eur J Cancer"},{"issue":"4","key":"10.1016\/j.ejca.2023.02.012_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002231","article-title":"Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade","volume":"9","author":"Banchereau","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"16","key":"10.1016\/j.ejca.2023.02.012_bib10","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1158\/1078-0432.CCR-20-0175","article-title":"Biomarkers associated with beneficial PD-1 checkpoint blockade in non-small cell lung cancer (NSCLC) identified using high-plex digital spatial profiling","volume":"26","author":"Zugazagoitia","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2023.02.012_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejca.2020.10.017","article-title":"Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non-small cell lung cancer treated with immunotherapy","volume":"145","author":"Gataa","year":"2021","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.ejca.2023.02.012_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/ol.2020.12350","article-title":"T lymphocytes related biomarkers for predicting immunotherapy efficacy in non-small cell lung cancer","volume":"21","author":"Wei","year":"2021","journal-title":"Oncol Lett"},{"issue":"7528","key":"10.1016\/j.ejca.2023.02.012_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/nature14011","article-title":"Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients","volume":"515","author":"Herbst","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejca.2023.02.012_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/path.5772","article-title":"Infiltration of NK and plasma cells is associated with a distinct immune subset in non-small cell lung cancer","volume":"255","author":"Backman","year":"2021","journal-title":"J Pathol"},{"issue":"8","key":"10.1016\/j.ejca.2023.02.012_bib15","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1158\/1078-0432.CCR-15-1507","article-title":"The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition","volume":"22","author":"Hegde","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ejca.2023.02.012_bib16","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jtho.2018.12.022","article-title":"Prognostic impact of tumor cell programmed death ligand 1 expression and immune cell infiltration in NSCLC","volume":"14","author":"Edlund","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"2","key":"10.1016\/j.ejca.2023.02.012_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2013.01.036","article-title":"The prognostic relevance of tumour-infiltrating plasma cells and immunoglobulin kappa C indicates an important role of the humoral immune response in non-small cell lung cancer","volume":"333","author":"Lohr","year":"2013","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.ejca.2023.02.012_bib18","first-page":"4490","article-title":"M2 tumor-associated macrophages promote tumor progression in non-small-cell lung cancer","volume":"18","author":"Sumitomo","year":"2019","journal-title":"Exp Ther Med"},{"issue":"6","key":"10.1016\/j.ejca.2023.02.012_bib19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1164\/rccm.201708-1707OC","article-title":"Circulating and tumor myeloid-derived suppressor cells in resectable non-small cell lung cancer","volume":"198","author":"Yamauchi","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejca.2023.02.012_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.lungcan.2018.01.022","article-title":"Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer","volume":"117","author":"Barua","year":"2018","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.ejca.2023.02.012_bib21","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1158\/1078-0432.CCR-18-2013","article-title":"Spatial architecture and arrangement of tumor-infiltrating lymphocytes for predicting likelihood of recurrence in early-stage non-small cell lung cancer","volume":"25","author":"Corredor","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2023.02.012_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.667067","article-title":"Multiplex immunofluorescence tyramide signal amplification for immune cell profiling of paraffin-embedded tumor tissues","volume":"8","author":"Hernandez","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"1","key":"10.1016\/j.ejca.2023.02.012_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.annonc.2021.09.021","article-title":"Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer","volume":"33","author":"Federico","year":"2022","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.ejca.2023.02.012_bib24","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1164\/rccm.201309-1611OC","article-title":"Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer","volume":"189","author":"Germain","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"37","key":"10.1016\/j.ejca.2023.02.012_bib25","doi-asserted-by":"crossref","first-page":"24801","DOI":"10.18632\/oncotarget.24835","article-title":"Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis","volume":"9","author":"Soo","year":"2018","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ejca.2023.02.012_bib26","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jtho.2016.01.020","article-title":"The impact of the fourth edition of the WHO classification of lung tumours on histological classification of resected pulmonary NSCCs","volume":"11","author":"Micke","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ejca.2023.02.012_bib27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1186\/s12885-016-2646-x","article-title":"Inconsistent results in the analysis of ALK rearrangements in non-small cell lung cancer","volume":"16","author":"Mattsson","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2023.02.012_bib28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.lungcan.2019.01.003","article-title":"Mutation patterns in a population-based non-small cell lung cancer cohort and prognostic impact of concomitant mutations in KRAS and TP53 or STK11","volume":"130","author":"La Fleur","year":"2019","journal-title":"Lung Cancer"},{"issue":"10","key":"10.1016\/j.ejca.2023.02.012_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86837","article-title":"Profiling cancer testis antigens in non-small-cell lung cancer","volume":"1","author":"Djureinovic","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/j.ejca.2023.02.012_bib30","series-title":"R: a language and environment for statistical computing","year":"2022"},{"issue":"18","key":"10.1016\/j.ejca.2023.02.012_bib31","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"issue":"16","key":"10.1016\/j.ejca.2023.02.012_bib32","doi-asserted-by":"crossref","first-page":"5247","DOI":"10.1158\/1078-0432.CCR-10-2805","article-title":"Prognostic immune markers in non-small cell lung cancer","volume":"17","author":"Suzuki","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.ejca.2023.02.012_bib33","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/eji.202048966","article-title":"Tumor infiltrated immune cell types support distinct immune checkpoint inhibitor outcomes in patients with advanced non-small cell lung cancer","volume":"51","author":"Ku","year":"2021","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.ejca.2023.02.012_bib34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00262-020-02506-x","article-title":"Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients","volume":"69","author":"Hurkmans","year":"2020","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10.1016\/j.ejca.2023.02.012_bib35","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1038\/s41467-018-05032-8","article-title":"A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers","volume":"9","author":"Gettinger","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ejca.2023.02.012_bib36","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/cancers11040470","article-title":"Immunology of plasmacytoid dendritic cells in solid tumors: a brief review","volume":"11","author":"Kouck\u00fd","year":"2019","journal-title":"Cancers"},{"issue":"11","key":"10.1016\/j.ejca.2023.02.012_bib37","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1200\/JCO.2015.63.0970","article-title":"Prognostic effect of tumor lymphocytic infiltration in resectable non-small-cell lung cancer","volume":"34","author":"Brambilla","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2023.02.012_bib38","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1183\/09031936.00065708","article-title":"Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival","volume":"33","author":"Ohri","year":"2009","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.ejca.2023.02.012_bib39","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2023.02.012_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.clim.2006.10.014","article-title":"Transient regulatory T-cells: a state attained by all activated human T-cells","volume":"123","author":"Pillai","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.ejca.2023.02.012_bib41","doi-asserted-by":"crossref","first-page":"104452","DOI":"10.1016\/j.ebiom.2023.104452","article-title":"An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers","volume":"88","author":"Mezheyeuski","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejca.2023.02.012_bib42","article-title":"Graph neural networks and their current applications in bioinformatics","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/j.ejca.2023.02.012_bib43","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/PAP.0000000000000264","article-title":"Explainable AI (xAI) for anatomic pathology","volume":"27","author":"Tosun","year":"2020","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.ejca.2023.02.012_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/path.893","article-title":"Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies","volume":"195","author":"Bubendorf","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2023.02.012_bib45","first-page":"EC40","article-title":"Breast biomarkers-comparison on whole section and tissue microarray section","volume":"11","author":"Chavan","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.ejca.2023.02.012_bib46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cllc.2019.02.012","article-title":"Programmed cell death ligand 1 immunohistochemistry: a concordance study between surgical specimen, biopsy, and tissue microarray","volume":"20","author":"Elfving","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ejca.2023.02.012_bib47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.oooo.2013.08.029","article-title":"Tissue microarray is a reliable method for immunohistochemical analysis of pleomorphic adenoma","volume":"117","author":"Fonseca","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923001004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804923001004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:39:37Z","timestamp":1760733577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804923001004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":47,"alternative-id":["S0959804923001004"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2023.02.012","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial immunophenotyping of the tumour microenvironment in non\u2013small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2023.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}